The Healing Context in Complementary and Alternative Medicine (CAM): Instrument Development and Initial Validation
HEAL
The Healing Context in CAM: Instrument Development and Initial Validation
1 other identifier
observational
72
1 country
1
Brief Summary
The overall objective of this study is to develop and test an efficient self-report instrument to measure Complementary and Alternative Medicine(CAM)-relevant contextual factors important in healing. The initial phase of the study involves developing and refining an item bank. During the initial 'item bank development' phase, the investigators will run focus groups and cognitive interviews with individuals who participate in CAM and conventional medicine interventions. The current protocol in ClinicalTrials.gov pertains only to the initial phase of the study involving focus groups and cognitive interviews. The next step of instrument development is called Calibration, and will involve administering the revised item bank to an internet sample and to persons who receive services in a CAM clinic and a conventional primary care setting. The items will be calibrated using item response theory and classical test theory. This will result in a computerized adaptive testing version of the instrument, as well as a static short form of the instrument. The final phase of the project will involve conducting initial validation studies of the instrument. The instrument will be called the Healing Encounters and Attitudes List (HEAL). The investigators will evaluate the convergent, discriminant, and predictive validity of the HEAL in a sample of 200 persons with chronic low back pain who are receiving physical therapy, chiropractic care, or mindfulness-based stress reduction. For convergent validity, the HEAL is expected to display moderate to large correlations with measures of similar constructs. The HEAL is expected to correlate modestly with self-report measures of general psychosocial functioning, in support of discriminant validity. Finally, HEAL score should account for a significant proportion of the variance in treatment outcome, supporting predictive validity.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2011
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 16, 2010
CompletedFirst Posted
Study publicly available on registry
December 24, 2010
CompletedStudy Start
First participant enrolled
January 1, 2011
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2015
CompletedStudy Completion
Last participant's last visit for all outcomes
August 1, 2015
CompletedFebruary 10, 2017
November 1, 2015
4.6 years
December 16, 2010
February 8, 2017
Conditions
Outcome Measures
Primary Outcomes (1)
Transcribed focus group information
Participants' opinions regarding factors that contribute to healing, such as important patient characteristics, provider characteristics, and environmental factors.
Baseline (generally same day as study enrollment, but baseline data collection may occur at a single study visit within 4 weeks of enrollment)
Secondary Outcomes (1)
Cognitive Interviews regarding items
Baseline (generally same day as study enrollment, but data collection may occur at a single study visit within 4 weeks of study enrollment)
Study Arms (1)
community members
Pittsburgh area community members, including people who attend an integrative medicine clinic and people who attend a conventional medicine clinic.
Eligibility Criteria
community sample, conventional primary care clinic, and integrative medicine clinic.
You may qualify if:
- age 18 or over
- Males and Females
- able to read, speak and understand English
- able to complete informed consent procedures
You may not qualify if:
- self reported History of schizophrenia or current psychotic symptoms
- self reported History of bipolar disorder
- self report of substance dependence within the past 6 months
- self reported history of organic neuropsychiatric syndromes (e.g., Alzheimer's, Parkinson's, dementia)
- Lack of willingness or ability to provide informed consent
- Subjects may only complete either 1.) focus group or 2.) cognitive interview
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
Related Publications (2)
Greco CM, Glick RM, Morone NE, Schneider MJ. Addressing the "It Is Just Placebo" Pitfall in CAM: Methodology of a Project to Develop Patient-Reported Measures of Nonspecific Factors in Healing. Evid Based Complement Alternat Med. 2013;2013:613797. doi: 10.1155/2013/613797. Epub 2013 Dec 19.
PMID: 24454501BACKGROUNDGreco CM, Yu L, Johnston KL, Dodds NE, Morone NE, Glick RM, Schneider MJ, Klem ML, McFarland CE, Lawrence S, Colditz J, Maihoefer CC, Jonas WB, Ryan ND, Pilkonis PA. Measuring nonspecific factors in treatment: item banks that assess the healthcare experience and attitudes from the patient's perspective. Qual Life Res. 2016 Jul;25(7):1625-34. doi: 10.1007/s11136-015-1178-1. Epub 2015 Nov 12.
PMID: 26563249RESULT
Related Links
Study Officials
- PRINCIPAL INVESTIGATOR
Carol M Greco, Ph.D.
University of Pittsburgh
Study Design
- Study Type
- observational
- Observational Model
- ECOLOGIC OR COMMUNITY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Psychiatry
Study Record Dates
First Submitted
December 16, 2010
First Posted
December 24, 2010
Study Start
January 1, 2011
Primary Completion
August 1, 2015
Study Completion
August 1, 2015
Last Updated
February 10, 2017
Record last verified: 2015-11